Hadassah

Hadassah MS Patient, Dov Guggenheim, Runs in Jerusalem Marathon

Monday, Mar 20 2017

Dov Guggenheim with all the MS runners
Dov Guggenheim, was born in 1996 in Passaic, NJ. His mother took him to Israel for a year when he was in elementary school. Since that day he knew he would be forever connected to Israel. 
 
When he was 16, Dov made Aliyah to Israel by himself, finishing high school at the scientific Yeshiva High School in Maale Adumim. 
 
From there, he volunteered for the integrated army service and yeshiva program, at Kibbutz Maale Gilboa.
However, things changed in October, 2015 when he was diagnosed with MS. He was only 19.He switched to Yeshivat Mahanyaim in Efrat, so that he can be treated at Hadassah hospital. MS did not stop Dov from continuing to live his life. With the help of Hadassah’s treatments, he currently studies and works part-time. Dov hopes to have a future in finance. He’s got a knack for investing. 
 
Since he is a strong Zionist, Dov always looks for ways to serve Israel in any way he can. He will be volunteering for military service in the nearby future. 
 
Regardless of his diagnosis, Dov signed up to run in the Jerusalem marathon to raise awareness for MS through the MS Center at Hadassah. He wanted to show that MS is not a death sentence and that with the right treatment, support, and mindset, truly anything is possible. 
"I'm running this marathon through the MS center at Hadassah, not only because of the great treatment that I have received there, but because they afford me the greatest chance to affect the most people, by garnering the most possible help, either through awareness or donations.”
 
Dov Guggenheim with Hadassah MS Center team
Dov Guggenheim with Hadassah MS Center team
Dov Guggenheim with Hadassah MS Center team
Dov, on the left, with two MS runners.
He's counting on Hadassah to come up with a cure! Find out how you can help today.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jun 12 2019

Multinational Study Reveals Reduction in Kidney Disease Progression with Diabetes Drug

In a large multinational study that revealed the effectiveness of a medicine called dapagliflozin in reducing cardiovascular death from heart failure among high-risk diabetic patients, the first sub-analysis of renal data has also identified a 47 percent drop in decline of kidney function and renal death.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

What Causes PMS? Hadassah Study Offers Answer, with Implications for Future Research

A new explanation for the mood swings, irritability, and depression, known as Premenstrual syndrome (PMS) has been suggested by a Hadassah Medical Organization study.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

Hadassah Confronts the Comeback of Measles

Measles, a disease we have not seen for a long time, has come back. In the past year and a half, Israel has seen over 4,000 cases, says Prof. Allon Moses, director of the Department of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Organization.

READ MORE ›
alt_text

Wednesday, May 29 2019

First Cath Lab Opens in Northern Neighborhoods of Jerusalem at Hadassah Mount Scopus

Hadassah Hospital Mount Scopus inaugurated the first advanced cardiac catheterization unit serving Jerusalem’s northern neighborhoods.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More